IRB #

STUDY00018029

Title

Prophylactic Tumor Treating Fields in Management of Patients with Small Cell Lung Cancer

Principal Investigator

Timur Mitin

Study Purpose

The goal of this study is to assess if the use of the Optune medical device for patients with small cell lung cancer helps reduce the chance of the cancer spreading to the brain. The Optune device is worn continuously on the head and generates electrical tumor-treatment fields.

Medical Condition(s)

Optune, tumor-treatment field, small cell lung cancer, extensive-stage, limited-stage.

Eligibility Criteria

Patients must be 22 years or older, have proven small cell lung cancer that has shown a positive response to treatment with chemotherapy and/or radiotherapy, have no other interfering cancers, and no implanted electrical devices.

Age Range

22 - 100

Healthy Volunteers Needed

No

Duration of Participation

The active portion of the study will involve up to one month of screening and followed by 12 months using the Optune device. Follow-up will be the standard of care for cancer and will be up to 5 additional years.

Minors Included

No

Contact

John Minger, CCRC
OHSU Radiation Oncology
mingerj@ohsu.edu
503-418-3247

Sponsor

Novocure, Inc.

Recruitment End

12/31/2020

Compensation Provided

No


Go Back